AION UT Debuts in Hong Kong: GAC Showcases 8 Flagship Models at 2025 International Automotive & Supply Chain Expo (Hong Kong)
HONG KONG, June 13, 2025 /CNW/ -- On June 12, the 2025 International Automotive & Supply Chain Expo (Hong Kong) opened. GAC showcased eight flagship models across its three major product-brands: GAC, AION, and HYPTEC—while unveiling "Hong Kong ACTION" – the localized implementation of its "One GAC 2.0" strategy – and announcing the global debut of GOVY AirCab, its first mass-produced flying car, alongside the Hong Kong debut of AION UT.
At this year's expo, GAC showcased eight models, four of which have already been launched in Hong Kong. The AION Y PLUS features quality, safety, and long-range capabilities, its seats can be fully reclined flat. The AION V, with high quality, high technology, and high safety, caters to the needs of families worldwide. The HYPTEC HT, a luxurious and intelligent electric SUV, features a stylish appearance and is equipped with seat ventilation, heating, and massage, providing users with exceptional travel experiences. The E9 PHEV received hundreds of orders upon its launch in Hong Kong in 2024, has gained popularity for combining luxury with strong performance, becoming a top choice in the new energy MPV segment.
The AION UT, GAC's global strategic model, made its regional debut. Designed by GAC's Milan Design Center, it features a bold aesthetic, spacious cabin, and AI voice assistant. Meeting both Chinese and European five-star safety standards, the AION UT will go on sale in Hong Kong later this year, offering a stylish and intelligent electric option for urban consumers.
Leveraging Hong Kong's influence on Southeast Asia's right-hand drive market, vehicles showcased at the expo also target the global right-hand drive market, which accounts for 30% of total vehicle sales worldwide. Consequently, GAC is accelerating its overseas production capacity layout. GAC's Indonesia Smart Factory, which commenced operations on June 12, will radiate across the ASEAN region.
At the expo, GAC officially unveiled the GOVY AirCab, advancing the development of the low-altitude economic ecosystem guided by the concept of "worry-free travel by 'one click'". GAC's self-developed third-generation GoMate humanoid robot served as the intelligent reception officer at the booth. It will be applied in public safety and other fields to support smart city development.
GAC remains committed to high value, pursuing a global expansion with distinctive GAC characteristics, and aims to deliver experiences that exceed expectations for global consumers.
View original content to download multimedia:https://www.prnewswire.com/news-releases/aion-ut-debuts-in-hong-kong-gac-showcases-8-flagship-models-at-2025-international-automotive--supply-chain-expo-hong-kong-302481122.html
SOURCE GAC
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2025/13/c9512.html
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
Innocan Pharma Announces Presentation of Narrative Review on Long-Acting Synthetic Cannabidiol for Chronic Pain at PAINWEEK Conference
HERZLIYA, Israel and CALGARY, AB, June 20, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, proudly announces that the recently published narrative review titled "Considering Long-Acting Synthetic Cannabidiol for Chronic Pain: A Narrative Review" (DOI: has been officially accepted for presentation at PAINWEEK 2025, the national conference on pain management, taking place this September in Las Vegas, Nevada. PAINWEEK is a prestigious event that brings together leading clinicians, researchers, and educators in the field of pain medicine, offering a unique platform to showcase innovative research and best practices. The narrative review, selected through a competitive peer-review process, provides important insights into the potential of synthetic cannabidiol (CBD), administered through extended-release formulations, as a well-tolerated, non-opioid analgesic alternative. Innocan is developing LPT-CBD, an innovative injectable liposomal drug product designed for the sustained release of synthetic CBD. Supported by multiple animal studies, LPT-CBD has demonstrated steady plasma CBD levels for up to four weeks, prolonged pain relief, and excellent tolerability—offering a promising alternative to current opioid medications and addressing the urgent need to reduce opioid dependency. LPT-CBD will be showcased at the PAINWEEK conference to thousands of healthcare professionals and potential pharmaceutical partners, positioning it at the forefront of groundbreaking non-opioid chronic pain management solutions. "We are honored to be included among the esteemed voices presenting at PAINWEEK this year," said Iris Bincovich, Chief Executive Officer of Innocan. "This recognition underscores our commitment to advancing evidence-based pain care and contributing meaningful research to the field." About Innocan: Innocan is an innovator in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, Innocan developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of synthetic CBD for non-opioid pain management. In the wellness sector, Innocan develops and markets a wide portfolio of high-performance self-care and beauty products to promote a healthier lifestyle. Under this segment Innocan carries on business through its 60% owned subsidiary, BI Sky Global Ltd., which focuses on advanced, targeted online sales. Contact Information: For Innocan Pharma Corporation:Iris Bincovich, CEO+1 5162104025+972-54-3012842+442037699377info@ NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE. Caution Regarding Forward-Looking Information Certain information set forth in this news release, including, without limitation, the Company's plans for human trials of its LPT-CBD platform, is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond Innocan's control. The forward-looking information contained in this news release is based on certain key expectations and assumptions made by Innocan, including expectations and assumptions concerning the anticipated benefits of the products, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion of production and distribution arrangements. Forward-looking information is subject to various risks and uncertainties that could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: global and local (national) economic, political, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and potential disruption of relationships with suppliers, manufacturers, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including import/export matters and the failure to obtain any required regulatory and other approvals (or to do so in a timely manner). The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, or the need for additional time to conclude and/or satisfy the manufacturing and distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release. A comprehensive discussion of other risks that impact Innocan can be found in Innocan's public reports and filings which are available under Innocan's profile at Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Innocan does not undertake to update, correct or revise any forward-looking information as a result of any new information, future events or otherwise, except as may be required by applicable law. Logo: View original content: SOURCE Innocan Pharma Corporation View original content: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 days ago
- Yahoo
GAC makes global debut of GOVY AirCab flying car at Hong Kong event
Guangzhou Automobile Group (GAC) made the global debut of its first mass-produced flying car, the GOVY AirCab, at the opening of the 2025 International Automotive & Supply Chain Expo in Hong Kong. The GOVY AirCab, developed by GAC GOVY, is claimed to be the world's first autonomous multirotor flying car intended for mass production. The vehicle features a composite carbon fibre body, quick 25-minute charging capability, and 'intelligent' low-altitude obstacle avoidance. It incorporates multiple redundant safety systems for power, energy, flight control, and communications. GAC announced that the pre-order price will not exceed 1.68m yuan ($0.23m). Demonstration operations will begin later this year in the Guangdong-Hong Kong-Macao Greater Bay Area, with deliveries expected by the end of 2026. GAC also presented eight vehicles at the expo among which four models, AION Y PLUS, AION V, HYPTEC HT, and the E9 PHEV have already been launched in the Hong Kong market. Outside of China, GAC has expanded its manufacturing operations to countries including Malaysia, Thailand, and Indonesia. According to the company, these facilities are equipped with the latest GAC Production System (GPS3.0), incorporating a global quality assurance framework, advanced intelligent manufacturing techniques, and rigorous quality control measures. Since 2025, GAC stated that it has launched its advanced intelligent technology brand, GAC ADiGO 6.0, along with the intelligent driving technology system, GAC ADiGO GSD, and the newly introduced GAC X-SOUL Safety Protection System. The company stated that it aims to become a leading player in intelligent driving assistance technology within China by 2025 and to rank among the global top tier in technological innovation and R&D capabilities by 2027. At the Shanghai Auto Show this April, GAC showcased the X-SOUL AI panorama, which is designed around four key scenarios—Sky, Robot, Home, and Vehicle—aiming to establish a 'new paradigm' in intelligent mobility. At the International Automotive & Supply Chain Expo, the company also announced its "Hong Kong ACTION", the localised implementation of "One GAC 2.0" global strategy in Hong Kong, as well as the Hong Kong launch of its global 'premium' compact model, AION UT. GAC president Wei Haigang: "GAC will fully leverage the advantages of its industrial system centered around our Panyu headquarters in Guangzhou, and will adhere to the principles of long-term commitment and win-win cooperation, and adopts a full industry chain ecosystem globalisation approach, focusing on Hong Kong consumers' needs, in Hong Kong, for Hong Kong, integrating into Hong Kong, serving Hong Kong, and contributing to Hong Kong. GAC aims to establish as a reliable automotive brand among Hong Kong consumers." "GAC makes global debut of GOVY AirCab flying car at Hong Kong event" was originally created and published by Just Auto, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 days ago
- Yahoo
Dynamic Funds announces securityholder approval for fund mergers and other changes and June 2025 cash distributions for Dynamic Active ETFs and ETF Series
TORONTO, June 18, 2025 /CNW/ - Securityholder approval for Dynamic Funds mergers 1832 Asset Management L.P., as manager of Dynamic Funds (the "Manager"), today announced that it has received securityholder approval at the special meetings of the securityholders held on June 18, 2025, to merge certain funds (the "Mergers"). The Mergers are expected to take effect on or about July 18, 2025. The following mutual funds (each, a "Terminating Fund") will be merged into the corresponding mutual fund (each, a "Continuing Fund") set out below: Terminating FundsContinuing Funds Merger Type Dynamic Credit Spectrum Fund to merge into Dynamic Active Credit Strategies Private Pool Taxable Dynamic European Equity Fund to merge into Dynamic International Dividend Private Pool Non-Taxable Additional information concerning the Mergers is contained in the meeting materials that were mailed to securityholders in connection with the special meetings and which are also available on and at Securityholder approval for Dynamic Strategic Resource Class – Investment Objective and Reference Index Change The Manager today announced that it has received securityholder approval to change the investment objective and the reference index for the performance fee and benchmark of Dynamic Strategic Resource Class, which will be renamed to Dynamic Strategic Mining Class. These changes are anticipated to be implemented on or about July 11, 2025. The investment objective of the fund will be changed to: Dynamic Strategic Mining Class seeks to provide long-term capital appreciation by investing primarily in global equity securities of companies involved in the exploration, development and production of physical commodities such as precious metals, base metals, critical minerals, uranium, rare earths and/or ferrous metals. The reference index for the performance fee and benchmark of the fund will be changed to MSCI World Metals and Mining Index (C$). Additional information concerning the investment objective and performance fee reference index changes is contained in the meeting materials that were mailed to securityholders in connection with the special meetings and which are also available on and at June 2025 cash distributions for Dynamic Active ETFs and ETF Series Dynamic Funds today announced the June 2025 cash distributions for the Dynamic Active ETFs and ETF series units of certain Dynamic Funds (ETF Series) listed on the TSX, which pay on a monthly or quarterly basis. Unitholders of record on June 25, 2025 will receive cash distributions for the respective Dynamic Active ETFs and ETF Series payable on June 30, 2025. The details of the cash distribution amounts per unit are as follows: Dynamic Active ETF Ticker symbol (TSX) Cash distribution per unit ($) Distribution frequency Dynamic Active Bond ETF DXBB 0.070 Monthly Dynamic Active Canadian Bond ETF DXBC 0.059 Monthly Dynamic Active Canadian Dividend ETF DXC 0.082 Monthly Dynamic Active Corporate Bond ETF DXCB 0.077 Monthly Dynamic Active Crossover Bond ETF DXO 0.091 Monthly Dynamic Active Discount Bond ETF DXDB 0.075 Monthly Dynamic Active Energy Evolution ETF DXET 0.003 Quarterly Dynamic Active Enhanced Yield Covered Options ETF DXQ 0.162 Monthly Dynamic Active Global Equity Income ETF DXGE 0.050 Monthly Dynamic Active Global Financial Services ETF DXF 0.100 Quarterly Dynamic Active Global Infrastructure ETF DXN 0.183 Quarterly Dynamic Active International Dividend ETF DXW 0.200 Monthly Dynamic Active Ultra Short Term Bond ETF DXV 0.053 Monthly Dynamic Active Preferred Shares ETF DXP 0.097 Monthly Dynamic Active Real Estate ETF DXRE 0.150 Quarterly Dynamic Active Retirement Income ETF DXR 0.087 Monthly Dynamic Active Tactical Bond ETF DXB 0.064 Monthly Dynamic Active U.S. Investment Grade Corporate Bond ETF DXBU 0.075 Monthly Dynamic Credit Opportunities Fund DXCO 0.112 Monthly Dynamic Global Fixed Income Fund DXBG 0.070 Monthly Dynamic Short Term Credit PLUS Fund DXCP 0.095 Monthly Commissions, trailing commissions, management fees and expenses may be associated with mutual fund investments, including exchange-traded funds (ETFs). Please read the prospectus before investing. The securities held by an ETF can change at any time without notice. Mutual funds and ETFs are not guaranteed, their values change frequently, and past performance may not be repeated. For more information about Dynamic Funds, please visit the Dynamic Funds website. About Dynamic Funds Dynamic Funds is a division of 1832 Asset Management L.P., which offers a range of wealth management solutions, including mutual funds, actively managed ETFs, liquid alternative mutual funds and investment solutions for private clients, institutions and managed asset programs. 1832 Asset Management L.P. is a limited partnership, the general partner of which is wholly owned by Scotiabank. Dynamic Funds® is a registered trademark of The Bank of Nova Scotia, used under license by 1832 Asset Management L.P. © Copyright 2025 The Bank of Nova Scotia. All rights reserved. Website: |Twitter: @DynamicFunds | LinkedIn: SOURCE Dynamic Funds View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
